Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04116996 · ClinicalTrials.gov registry record · NA

Globus Pallidus Stimulation to Treat Insomnia

A NA study of Parkinson Disease, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04116996 is a NA study of Parkinson Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04116996, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Researchers are to determine if turning on an additional unilateral DBS (deep brain stimulation) electrode with stimulation to the globus pallidus externa (GPe) region of the brain will improve insomnia (sleep).

Conditions Studied

Interventions

  • DEVICE DEEP BRAIN STIMULATION

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-01-01
Est. Completion 2029-01-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04116996

The ClinicalTrials.gov registry entry for NCT04116996 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which DEEP BRAIN STIMULATION is the first listed.

NCT04116996 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04116996 about?

NCT04116996 is a clinical study titled "Globus Pallidus Stimulation to Treat Insomnia". Researchers are to determine if turning on an additional unilateral DBS (deep brain stimulation) electrode with stimulation to the globus pallidus externa (GPe) region of the brain will improve insomnia (sleep).

What is the current status of trial NCT04116996?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2019-01-01. Estimated completion is 2029-01-01.

What conditions does trial NCT04116996 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT04116996?

The interventions under investigation include: DEEP BRAIN STIMULATION (DEVICE).

Who is sponsoring clinical trial NCT04116996?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04116996 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.